Advances in classification and targeted therapy of gliomas

被引:0
|
作者
Wen, P. [1 ]
机构
[1] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA
关键词
D O I
10.1016/j.jns.2017.08.121
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
96
引用
收藏
页码:28 / 28
页数:1
相关论文
共 50 条
  • [1] Advances in the molecular genetics of gliomas - implications for classification and therapy
    Reifenberger, Guido
    Wirsching, Hans-Georg
    Knobbe-Thomsen, Christiane B.
    Weller, Michael
    NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (07) : 434 - 452
  • [2] Advances in the molecular genetics of gliomas — implications for classification and therapy
    Guido Reifenberger
    Hans-Georg Wirsching
    Christiane B. Knobbe-Thomsen
    Michael Weller
    Nature Reviews Clinical Oncology, 2017, 14 : 434 - 452
  • [3] Targeted Therapy in Gliomas
    Hamza, Mohamed Ali
    Gilbert, Mark
    CURRENT ONCOLOGY REPORTS, 2014, 16 (04)
  • [4] Targeted Therapy in Gliomas
    Mohamed Ali Hamza
    Mark Gilbert
    Current Oncology Reports, 2014, 16
  • [5] Advances in targeted therapy for osteosarcoma based on molecular classification
    Chen, Yingqian
    Liu, Runzhi
    Wang, Wei
    Wang, Chen
    Zhang, Ning
    Shao, Xuejing
    He, Qiaojun
    Ying, Meidan
    PHARMACOLOGICAL RESEARCH, 2021, 169
  • [6] Immunotherapy and targeted therapy of gliomas
    Werner J.-M.
    Ceccon G.
    Fink G.R.
    Galldiks N.
    best practice onkologie, 2022, 17 (9) : 446 - 456
  • [7] Targeted therapy for malignant gliomas
    Morokoff, AP
    Novak, U
    JOURNAL OF CLINICAL NEUROSCIENCE, 2004, 11 (08) : 807 - 818
  • [8] Advances in targeted therapy
    Breedveld, Ferry C.
    Kalden, Joachim R.
    Smolen, Josef S.
    RHEUMATOLOGY, 2016, 55 : 1 - 2
  • [9] Targeted molecular therapy of malignant gliomas
    Kesari S.
    Ramakrishna N.
    Sauvageot C.
    Stiles C.D.
    Wen P.Y.
    Current Neurology and Neuroscience Reports, 2005, 5 (3) : 186 - 197
  • [10] Targeted therapy in the treatment of malignant gliomas
    Lukas, Rimas V.
    Boire, Adrienne
    Nicholas, M. Kelly
    ONCOTARGETS AND THERAPY, 2009, 2 : 115 - 133